J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports
By Thomson ReutersJan 12, 2025 | 5:18 PM
(Reuters) – Johnson & Johnson is exploring a bid to acquire Intra-Cellular Therapies Inc, a biopharmaceutical company, Bloomberg News reported on Sunday citing people familiar with the matter.
(Reporting by Angela Christy in Bengaluru; Editing by Sandra Maler)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at (517) 279-1590.
Comments